Lakewood-Amedex Biotherapeutics Inc. is a clinical-stage biopharmaceutical company based in Sarasota, Florida, dedicated to the discovery and development of a novel class of anti-infective agents. The company's proprietary technology platform, known as Bisphosphocins™, consists of synthetic, small-molecule compounds designed to address the growing global threat of multi-drug resistant (MDR) bacterial, viral, and fungal infections. Unlike traditional antibiotics that often target specific metabolic pathways, Bisphosphocins utilize a unique mechanism of action that rapidly disrupts the bacterial cell membrane. This physical mode of action makes it significantly more difficult for pathogens to develop resistance, offering a potential breakthrough for patients who have exhausted conventional treatment options. The company's lead product candidate, Nu-3, is being developed as a topical and systemic antimicrobial. It has been studied for the treatment of infected diabetic foot ulcers and other chronic wounds where biofilm and resistant bacteria are prevalent. Beyond wound care, Lakewood-Amedex is exploring the application of its platform for respiratory tract infections and other systemic indications. The company aims to leverage its intellectual property and clinical data to form strategic partnerships and advance its pipeline through the regulatory approval process to meet the urgent need for effective new anti-infectives.
The sum of declared dividends issued by a company for every ordinary share outstanding.
Dividend Yield is a financial ratio that shows how much a company pays out in dividends each year relative to its share price in the last twelve months. In the absence of any capital gains, the dividend yield is the return on investment for a stock.
It is another way that companies have to remunerate their shareholders, being an alternative to dividends. Shows the % of repurchases per share made in the last 12 months in relation to the share price.
Sum of Dividend Yield and BuyBack Yield to show the total return that the shareholder received in the last 12 months in relation to the share price.
The dividend payout ratio is the ratio of the total amount of dividends paid out to shareholders relative to the net income of the company. It is the percentage of earnings paid to shareholders via dividends.
Retained earnings (RE) are the amount of net income left over for the business after it has paid out dividends to its shareholders and are an important variable for assessing a company's financial health because it shows the net income that a company has saved over time, and therefore has the ability to reinvest in the business or distribute to shareholders.
...and much more!